Literature DB >> 24475464

Steroids for acute COPD--but for how long?

Gary N Asher1, Anne Mounsey.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24475464      PMCID： PMC3890440     

Source DB:  PubMed          Journal:  J Fam Pract        ISSN： 0094-3509            Impact factor:   0.493


× No keyword cloud information.
  6 in total

Review 1.  Different durations of corticosteroid therapy for exacerbations of chronic obstructive pulmonary disease.

Authors:  Julia Ae Walters; Wendy Wang; Carla Morley; Amir Soltani; Richard Wood-Baker
Journal:  Cochrane Database Syst Rev       Date:  2011-10-05

Review 2.  Contemporary management of acute exacerbations of COPD: a systematic review and metaanalysis.

Authors:  Bradley S Quon; Wen Qi Gan; Don D Sin
Journal:  Chest       Date:  2008-03       Impact factor: 9.410

3.  Severe acute exacerbations and mortality in patients with chronic obstructive pulmonary disease.

Authors:  J J Soler-Cataluña; M A Martínez-García; P Román Sánchez; E Salcedo; M Navarro; R Ochando
Journal:  Thorax       Date:  2005-07-29       Impact factor: 9.139

4.  Effect of systemic glucocorticoids on exacerbations of chronic obstructive pulmonary disease. Department of Veterans Affairs Cooperative Study Group.

Authors:  D E Niewoehner; M L Erbland; R H Deupree; D Collins; N J Gross; R W Light; P Anderson; N A Morgan
Journal:  N Engl J Med       Date:  1999-06-24       Impact factor: 91.245

5.  Short-term vs conventional glucocorticoid therapy in acute exacerbations of chronic obstructive pulmonary disease: the REDUCE randomized clinical trial.

Authors:  Jörg D Leuppi; Philipp Schuetz; Roland Bingisser; Michael Bodmer; Matthias Briel; Tilman Drescher; Ursula Duerring; Christoph Henzen; Yolanda Leibbrandt; Sabrina Maier; David Miedinger; Beat Müller; Andreas Scherr; Christian Schindler; Rolf Stoeckli; Sebastien Viatte; Christophe von Garnier; Michael Tamm; Jonas Rutishauser
Journal:  JAMA       Date:  2013-06-05       Impact factor: 56.272

Review 6.  Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary.

Authors:  Klaus F Rabe; Suzanne Hurd; Antonio Anzueto; Peter J Barnes; Sonia A Buist; Peter Calverley; Yoshinosuke Fukuchi; Christine Jenkins; Roberto Rodriguez-Roisin; Chris van Weel; Jan Zielinski
Journal:  Am J Respir Crit Care Med       Date:  2007-05-16       Impact factor: 21.405
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.